.

.

.

3D Printing: Enabling the Future of Healthcare 

Hosted by the Royal Pharmaceutical Society and
the Academy of Pharmaceutical Sciences

Thursday 3 July 2025, 10.30am - 6.30pm

Royal Pharmaceutical Society,  London, E1W 1AW 

Step into the future of healthcare and explore the limitless possibilities of 3D printing at our event in collaboration with the Academy of Pharmaceutical Sciences.  

We invite pharmacy professionals, other clinicians, researchers, industry leaders and regulators to join us to explore the transformative potential of this cutting-edge technology, which is set to revolutionise the pharmaceutical landscape and deliver unparalleled patient care. 

Through a curated line-up of expert speakers, including Keynote Speaker Professor Abdul Basit, and other thought leaders including Stephen Tomlin, this one-day event will: 

  • Showcase real-world examples of 3D printing in pharmaceuticals, from personalised medicine and on-demand drug manufacturing to innovative dosage forms that promise to reshape the industry.
  • Discuss and examine technical limitations, and highlight current gaps in research, manufacturing scalability, and the implementation of 3D printing in routine pharmacy practice.
  • Cover essential regulatory considerations and emerging guidelines for integrating this technology into clinical and industrial settings
  • Celebrate innovative research in the field with the opportunity to showcase your research or explore that of your peers in our Poster Zone on-site throughout the day – find out more below.

From the event, we will develop a roadmap for future implementation, proposing strategies to accelerate 3D printing adoption while ensuring safety and compliance with MHRA regulations. 

View our full list of speakers here.

 

Learning objectives
By attending this event, you will:

  • Understand the fundamentals of 3D printing in pharmaceuticals and its impact on healthcare.
  • Explore real-world applications of 3D printing, including patient-specific medicines and novel drug delivery systems.
  • Gain insights into regulatory challenges and the evolving guidelines for implementing 3D printing in clinical and industrial settings.
  • Identify key barriers to adoption, including quality assurance, cost-effectiveness, and manufacturing scalability.
  • Learn from industry experts, researchers, and policymakers about the future of 3D printing in routine pharmacy practice.
  • Contribute to the development of a strategic roadmap for safe and efficient integration of 3D printing in healthcare
  • Be able to network with peers over a hot buffet lunch and post-event drinks reception.
     

 Who is this event for?

  • Pharmacists – Learn how 3D printing can enhance pharmaceutical compounding, personalised medicine, and drug formulation. Gain insights into its potential role in hospital and community pharmacy settings
  • Clinicians – Explore how tailor-made medicines can revolutionise treatment plans, particularly in areas like oncology, paediatrics, and rare diseases
  • Researchers – Stay ahead of the curve by discovering cutting-edge research and development in pharmaceutical 3D printing
  • Industry Leaders and Regulators – Gain clarity on emerging regulatory frameworks, quality control challenges, and market readiness for integrating 3D printing in pharmaceutical manufacturing.

 

Registration fees

    Ticket Type Fee
    RPS/APS members £100                     
    RPS/APS foundation trainee/students/post doc £70
    Non-members £215
    Non-member foundation trainee/students £185